9.1.3 Biostatistics Core. Statistics provides a foundation for the design, conduct and analysis of experiments and studies based on data subject to random variation. Consequently, biostatistical support is critical to many investigators at the Winship Cancer Institute and biostatisticians play a fundamental role in both pre- and post-funding award stages of most cancer research studies. The Biostatistics Shared Core Resource in the WCI is a shared institutional resource for biostatistical consulting and related methodological research. It is recognized as a critical component of the research infrastructure at WCI. The Shared Resource serves as a focal point from which Center investigators may draw statistical expertise for planning, management, and analysis of their studies. The Biostatistics Shared Core includes the following services: 1) Provides statistical expertise in the design of experiments and studies, including research proposal development, sample size determination, randomization procedures, and plans for interim reviews and final analysis;2) Assists with the writing of statistical components of manuscripts;3) Reviews, in conjunction with the Clinical Translational Research Committee (CTRC), the integrity and statistical soundness of all studies involving human subjects;4) Interacts and collaborates with the Clinical Trials Office in the development of protocols, and the monitoring and reporting of clinical data;5) Conducts biostatistical methodology research on practical problems arising in cancer studies, such as mathematical modeling, applicable to cancer research. Types of research supported include clinical trials, translational research, epidemiology, behavioral, and basic science. The Biostatistics Shared Resource spans all Programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
1P30CA138292-01
Application #
7944903
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-04-07
Project End
2012-03-31
Budget Start
2009-04-07
Budget End
2010-03-31
Support Year
1
Fiscal Year
2009
Total Cost
$71,702
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Zhong, Jim; Switchenko, Jeffrey; Behera, Madhusmita et al. (2018) Chemotherapy with or Without Definitive Radiation Therapy in Inoperable Pancreatic Cancer. Ann Surg Oncol 25:1026-1033
Halicek, Martin; Little, James V; Wang, Xu et al. (2018) Optical Biopsy of Head and Neck Cancer Using Hyperspectral Imaging and Convolutional Neural Networks. Proc SPIE Int Soc Opt Eng 10469:
Ferris, Matthew J; Zhong, Jim; Switchenko, Jeffrey M et al. (2018) Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy. Radiother Oncol 126:100-106
Xiao, Canhua; Beitler, Jonathan J; Higgins, Kristin A et al. (2018) Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer. Cancer 124:3163-3170
Danish, Hasan; Ferris, Matthew J; Balagamwala, Ehsan et al. (2018) Comparative outcomes and toxicities for ruthenium-106 versus palladium-103 in the treatment of choroidal melanoma. Melanoma Res 28:120-125
Barwick, Benjamin G; Scharer, Christopher D; Martinez, Ryan J et al. (2018) B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation. Nat Commun 9:1900
Liu, Fakeng; Liu, Yuan; Liu, Xiuju et al. (2018) Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer. Lung Cancer 123:36-43
Kennedy, E M; Powell, D R; Li, Z et al. (2018) Galactic Cosmic Radiation Induces Persistent Epigenome Alterations Relevant to Human Lung Cancer. Sci Rep 8:6709
Xiao, Canhua; Beitler, Jonathan J; Higgins, Kristin A et al. (2018) Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer. Brain Behav Immun 74:291-295
Cassidy, Richard J; Zhang, Xinyan; Switchenko, Jeffrey M et al. (2018) Health care disparities among octogenarians and nonagenarians with stage III lung cancer. Cancer 124:775-784

Showing the most recent 10 out of 331 publications